News
-
-
-
-
PRESS RELEASE
Viromed Medical AG: Annual General Meeting approves all proposed resolutions by a large majority
Viromed Medical AG's Annual General Meeting approves all proposed resolutions by a large majority. New Supervisory Board member elected, authorised capital replaced, and focus on innovation highlighted -
-
-
PRESS RELEASE
Viromed Medical AG enters into a distribution partnership with TriPart for the market launch of ViroCAP® and PulmoPlas® in Turkey
Viromed Medical AG partners with TriPart for market launch of ViroCAP® and PulmoPlas® in Turkey. New distribution agreement to introduce innovative medical technology products in Q1 2026 -
-
-
PRESS RELEASE
EQS-Adhoc: Viromed Medical AG expects dynamic growth and announces forecast for 2025 and 2026
Viromed Medical AG expects dynamic growth with revenue forecasted to reach around EUR 8-10 million in 2025 and around EUR 80 million in 2026. The EBIT margin is expected to be in the double-digit range from 2026 onwards